Telesis Bio, Inc.
CYSTINE CATIONIC LIPIDS

Last updated:

Abstract:

The present invention provides, in part cystine cationic lipid compounds of formula A, and sub-formulas thereof: or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly can be useful for treating various diseases, disorders and conditions, such as those associated with deficiency of one or more proteins. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

17 Apr 2020

Issue date:

9 Jun 2022